Use of Cefiderocol in the Management of Children With Infection or Colonization With Multi-drug Resistant Gram-negative Bacteria: A Retrospective, Single-center Case Series

被引：1
作者：
Schmid, Hanna [1 ]
Brown, Li-An K. [2 ]
Indrakumar, Bairavi [3 ]
McGarrity, Orlagh [3 ]
Hatcher, James [2 ]
Bamford, Alasdair [1 ,4 ]
机构：
[1] Great Ormond St Hosp Children NHS Fdn Trust, Paediat Infect Dis, Great Ormond St, London WC1N 3JH, England
[2] Great Ormond St Hosp Children NHS Fdn Trust, Dept Microbiol, Lab Med, London, England
[3] Great Ormond St Hosp Children NHS Fdn Trust, Pharm Dept, London, England
[4] UCL Great Ormond St Inst Child Hlth, Infect Immun & Inflammat Dept, London, England
来源：
PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2024年 / 43卷 / 08期
关键词：
antimicrobial resistance; cefiderocol; multidrug-resistant Gram-negative bacteria; novel antimicrobials; pediatric;
D O I：
10.1097/INF.0000000000004347
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Cefiderocol, a novel siderophore cephalosporin, represents a treatment option for infections with multidrug-resistant Gram-negative bacteria, of which rates are rising worldwide. Clinical data on its use in children is limited. In our pediatric case series, the largest reported to date, cefiderocol seems safe and well tolerated, with more favorable clinical outcomes when compared to the literature reviewing adult cases.
引用
收藏
页码：772 / 776
页数：5
相关论文
共 12 条
  • [1] Long-Term Compassionate Use of Cefiderocol To Treat Chronic Osteomyelitis Caused by Extensively Drug-Resistant Pseudomonas aeruginosa and Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae in a Pediatric Patient
    Alamarat, Zain, I
    Babic, Jessica
    Tran, Truc T.
    Wootton, Susan H.
    Dinh, An Q.
    Miller, William R.
    Hanson, Blake
    Wanger, Audrey
    Gary, Joshua L.
    Arias, Cesar A.
    Perez, Norma
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (04)
  • [2] [Anonymous], 2023, Paediatric drug optimization for antibiotics: meeting report, 30 November, 5-7 December 2022
  • [3] [Anonymous], European Committee on Antimicrobial Susceptibilty Testing (EUCAST)
  • [4] Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
    Bassetti, Matteo
    Echols, Roger
    Matsunaga, Yuko
    Ariyasu, Mari
    Doi, Yohei
    Ferrer, Ricard
    Lodise, Thomas P.
    Naas, Thierry
    Niki, Yoshihito
    Paterson, David L.
    Portsmouth, Simon
    Torre-Cisneros, Julian
    Toyoizumi, Kiichiro
    Wunderink, Richard G.
    Nagata, Tsutae D.
    [J]. LANCET INFECTIOUS DISEASES, 2021, 21 (02) : 226 - 240
  • [5] Cefiderocol as Salvage Therapy for Carbapenem-Resistant Klebsiella pneumoniae Sepsis in an Extremely Preterm Neonate
    Bawankule, Sameer
    Nabar, Neha
    Joshi, Preetha
    Singhal, Tanu
    [J]. INDIAN JOURNAL OF PEDIATRICS, 2023, 90 (03) : 310 - 310
  • [6] Treatment of carbapenem-resistant Pseudomonas aeruginosa infections: a case for cefiderocol
    Canton, Rafael
    Doi, Yohei
    Simner, Patricia J.
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (08) : 1077 - 1094
  • [7] Combining bacteriophages with cefiderocol and meropenem/vaborbactam to treat a pan-drug resistant Achromobacter species infection in a pediatric cystic fibrosis patient
    Gainey, Andrew B.
    Burch, Anna-Kathryn
    Brownstein, Michael J.
    Brown, David E.
    Fackler, Joseph
    Horne, Bri'Anna
    Biswas, Biswajit
    Bivens, Brittany N.
    Malagon, Francisco
    Daniels, Robert
    [J]. PEDIATRIC PULMONOLOGY, 2020, 55 (11) : 2990 - 2994
  • [8] Real-world clinical outcome of cefiderocol for treatment of multidrug-resistant non-fermenting, gram negative bacilli infections: a case series
    Hoellinger, Baptiste
    Simand, Celestine
    Jeannot, Katy
    Garijo, Carlos
    Cristinar, Mircea
    Reisz, Fanny
    Danion, Francois
    Ursenbach, Axel
    Lefebvre, Nicolas
    Boyer, Pierre
    Hansmann, Yves
    Studer, Antoine
    Schramm, Frederic
    Ruch, Yvon
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (03) : 393 - 395
  • [9] Successful Treatment of Persistent Stenotrophomonas maltophilia Bacteremia With Cefiderocol in an Infant
    Hsu, Alice J.
    Simner, Patricia J.
    Bergman, Yehudit
    Mathers, Amy J.
    Tamma, Pranita D.
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (04):
  • [10] Bloodstream Infection Due to a VIM-Metallo-β-Lactamase-Producing Klebsiella pneumoniae Treated with Cefiderocol in a Preterm Newborn
    Monari, Caterina
    Spagnuolo, Ferdinando
    Pisaturo, Mariantonietta
    Ascione, Serena
    Donnarumma, Giovanna
    Calo, Federica
    Caredda, Elisabetta
    Montella, Fortunato
    Maietta, Anna
    Montaldo, Paolo
    Pugliese, Umberto
    Galdiero, Massimiliano
    Carpentieri, Mauro
    Coppola, Nicola
    [J]. INFECTIOUS DISEASES AND THERAPY, 2023, 12 (02) : 727 - 734
12